Engineering recombinant proteins for structural and functional studies 2023

Engineering recombinant proteins for structural and functional studies 2023

Join us at Engineering recombinant proteins for structural and functional studies 2023

Date: 27 - 28 November

Location: The Spine Building 2 Paddington Village Liverpool L7 3FA , UK

 

 

We are excited to announce that Biotrend is sponsoring and be part of the Engineering recombinant proteins for structural and functional studies 2023 event.

This two-day training event will discuss strategies to engineer sufficiently pure, homogenous and high-quality recombinant proteins that are critical for subsequent structural and functional studies. The event, aimed at early career researchers will cover the latest bioinformatic tools for construct design and protein characterisation, tips and tricks for improving protein expression, purification, stability/preparation and evaluating quality with biophysical techniques. The event will be interactive with opportunities to bring proteins to analyse on some of the latest instrumentation/software and to present a poster on these topics. 

Topics will include:  

  • Protein Bioinformatics 
  • Protein Expression
  • Protein Purification 
  • Biophysical Characterisation 

Key learning objectives:

1. To be able to demonstrate knowledge of the full pathway of protein construct design, expression, purification and characterisation.

2. To be able to describe the principles and applications of bioinformatic and biophysical approaches to their research and have a chance to collect/analyse data on their protein of interest.

3. To understand how to optimise and evaluate protein expression and purification.

Programme Coordinators for this event are:

  • Nicola Burgess-Brown, Exact Sciences Innovation, Oxford
  • Rivka Isaacson, Kings College London
  • Elliott Stollar, University of Liverpool

Invited speakers for this event are:

  • Rod Chalk, Centre for Medicines Discovery (CMD), University of Oxford
  • Chris Cooper, CHARM Therapeutics
  • Mark Frost, Cytiva
  • Magdalena Richter, AstraZeneca
  • Dan Rigden, University of Liverpool
  • Eleanor Williams, Centre for Medicines Discovery (CMD), University of Oxford

 

for more information, please visit  the website event